BBNX
Beta Bionics, Inc.
NASDAQ · Healthcare · Medical - Equipment & Services · US
$16.95
+12.25%Next report
Analyst consensus
- Next report date
- Mar 30, 2027
- EPS estimate
- -$0.50
- Revenue estimate
- $30.4M
Latest reported
- Last report date
- Oct 27, 2026
- EPS actual
- -$0.52
- EPS estimate
- -$0.52
- Revenue actual
- $35.5M
- Revenue estimate
- $34.7M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +11.4%
- Revenue beats (12Q)
- 6
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $24
- PT range
- $16 – $30
- Analysts
- 9
5 Buy4 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 27, 2026 | -$0.52 | -$0.52 | Beat 0.64% | $35.5M |
| Jul 29, 2026 | -$0.58 | -$0.53 | Beat 8.78% | $32.0M |
| Apr 21, 2026 | -$0.53 | -$0.49 | Beat 7.55% | $27.6M |
| Feb 17, 2026 | -$0.42 | -$0.30 | Beat 28.57% | $32.1M |
| Oct 28, 2025 | -$0.45 | -$0.33 | Beat 26.67% | $27.3M |
| Jul 29, 2025 | -$0.51 | -$0.39 | Beat 23.53% | $23.2M |
| Mar 25, 2025 | -$0.42 | -$1.82 | Miss -333.33% | $20.4M |
| Dec 31, 2023 | — | -$3.13 | — | $8.3M |
| Sep 30, 2023 | — | -$1.71 | — | $3.1M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 30, 2027